Median Diagnostics Inc. (XKON:233250)

Market Cap	20.05B
Revenue (ttm)	7.86B
Net Income (ttm)	-567.58M
Shares Out	1.75M
EPS (ttm)	-496.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	37
Open	12,490
Previous Close	12,400
Day's Range	11,500 - 12,490
52-Week Range	10,190 - 17,990
Beta	0.16
RSI	43.60
Earnings Date	n/a

About Median Diagnostics

Median Diagnostics Inc. manufactures and sells veterinary medicines and diagnostic reagents. The company’s products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and antigens for human diagnostics. It also offers mouse and rat path...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1999
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 233250